Genomic profiling using targeted ultra-deep next-generation sequencing for prediction of treatment outcome after concurrent chemoradiation: Results from the German ARO-0401 trial.

被引：3
|
作者：
Tinhofer, Inge
Budach, Volker
Endris, Volker
Stenzinger, Albrecht
Weichert, Wilko
机构：
[1] Charite, Dept Radiooncol CCM CVK, Berlin, Germany
[2] Univ Hosp, Inst Pathol, Heidelberg, Germany
[3] Natl Ctr Tumor Dis, Heidelberg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.6002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6002
引用
收藏
页数：1
相关论文
共 2 条
  • [1] Genomic profiling using targeted ultra-deep next-generation sequencing for prediction of treatment outcome after concurrent chemoradiation of locally advanced head and neck cancer
    Tinhofer, I
    Budach, V
    Stenzinger, A.
    Weichert, W.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 118 - 118
  • [2] Next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck (LASCCHN) for assessment of mutational patterns and their interference with outcome after adjuvant chemoradiation: Results from a multicenter biomarker study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
    Tinhofer, I
    Budach, V
    Linge, A.
    Lohaus, F.
    Gkika, E.
    Stuschke, M.
    Balermpas, P.
    Roedel, C.
    Avlar, M.
    Grosu, A. L.
    Abdollahi, A.
    Debus, J.
    Belka, C.
    Pigorsch, S.
    Combs, S. E.
    Moennich, D.
    Zips, D.
    Weichert, W.
    Krause, M.
    Baumann, M.
    Oncology Research and Treatment, 2015, 38 : 176 - 176
1